The present study shows that MTC post-treatment reduces the expression of Bim, cleaved-caspase-12, IP3, GRP78 and CHOP protein levels (Figure 7b,c), and the results are consistent with previous studies. The gene discussed is BCL2L11; the disease is medullary thyroid gland carcinoma.